Gynecologic Cancer Clinical Trials

91 recruitingLast updated: June 17, 2026

There are 91 actively recruiting gynecologic cancer clinical trials across 24 countries. Studies span Not Applicable, Phase 2, Phase 1, Phase 3, Early Phase 1, Phase 4. Top locations include Toronto, Ontario, Canada, New York, New York, United States, Roma, Italy. Updated daily from ClinicalTrials.gov.


Gynecologic Cancer Trials at a Glance

91 actively recruiting trials for gynecologic cancer are listed on ClinicalTrialsFinder across 6 cities in 24 countries. The largest study group is Not Applicable with 44 trials, with the heaviest enrollment activity in Toronto, New York, and Roma. Lead sponsors running gynecologic cancer studies include Fondazione Policlinico Universitario Agostino Gemelli IRCCS, University of Utah, and Memorial Sloan Kettering Cancer Center.

Browse gynecologic cancer trials by phase

Treatments under study

About Gynecologic Cancer Clinical Trials

Looking for clinical trials for Gynecologic Cancer? There are currently 71 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Gynecologic Cancer trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Gynecologic Cancer clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 91 trials

Recruiting
Phase 2

Single Dose Investigator Initiated Pilot Study to Investigate CYTALUX (Pafolacianine) for Intraoperative Detection of Malignant Tissue in Subjects Undergoing Surgical Resection for Cancer.

Gynecologic CancersEsophageal CancerGastrointestinal Cancers
John Waters50 enrolled1 locationNCT07039526
Recruiting
Not Applicable

Cryocompression to Reduce Chemotherapy-induced Peripheral Neuropathy in Gynecologic Cancer - COHORT 2

Chemotherapy Induced Peripheral NeuropathyGynecologic Cancer
Duke University190 enrolled4 locationsNCT06139458
Recruiting
Phase 2

A Study to Assess Change in Disease Activity and Adverse Events in Adult Participants With Gynecologic Cancers Receiving Intravenous Infusion of IMGN151 as Monotherapy or in Combination With Other Therapies

Gynecologic CancersFallopian Tube CancerPlatinum-sensitive Ovarian Cancer+1 more
AbbVie377 enrolled16 locationsNCT07024784
Recruiting
Not Applicable

Communication About Sexual Health in Gynecologic Cancer

Gynecologic Cancers
Fox Chase Cancer Center200 enrolled1 locationNCT06904339
Recruiting
Not Applicable

Transcranial Magnetic Stimulation for Chemotherapy-Induced Peripheral Neuropathy in Breast and Gynecologic Cancer Survivors

Breast Cancer FemaleGynecologic Cancer
University of Utah19 enrolled1 locationNCT07120100
Recruiting

Pilot Observational Study of an Integrative Cure Stay Program

Breast CancerGynecologic Cancer
University Hospital, Basel, Switzerland30 enrolled1 locationNCT07398079
Recruiting

Genetic & Pathological Studies of BRCA1/BRCA2: Associated Tumors & Blood Samples

Breast CancerGynecologic CancersOvarian Cancer+1 more
Stanford University3,300 enrolled1 locationNCT01034033
Recruiting
Phase 1

Brodalumab in the Treatment of Immune-Related Adverse Events

Breast CancerLiver CancerEsophageal Cancer+15 more
Brian Henick, MD11 enrolled1 locationNCT06673329
Recruiting
Phase 2

Romiplostim N01 Plus ATRA for Persistent Isolated Chemotherapy-Induced Thrombocytopenia After Complete Remission of Gynecologic, Breast, or Lung Solid Tumors

Breast CancerGynecologic CancersOvarian Cancer+7 more
Peking University People's Hospital220 enrolled1 locationNCT07586826
Recruiting

Study of High-Precision Evaluation of Molecular ResiduaL Disease Through a PlatfOrm for Cancer TracKing and Interception (SHERLOCK)

Breast CancerLung CancerMelanoma+7 more
University Health Network, Toronto7,000 enrolled1 locationNCT07524114
Recruiting
Phase 2

A Study of Avutometinib (VS-6766) and Defactinib in People With Mesonephric Gynecologic Cancer

Mesonephric Gynecologic Cancer
Memorial Sloan Kettering Cancer Center40 enrolled7 locationsNCT05787561
Recruiting

The Surveillance, Epidemiology, and End Results Database Program on Endometrial Cancer in the Italian Population

Gynecologic CancerEndometrium Cancer
Fondazione Policlinico Universitario Agostino Gemelli IRCCS10,000 enrolled1 locationNCT07558889
Recruiting
Not Applicable

CARE Tool Study Aim 3

Colorectal, CancerProstate CancerLung Cancer+1 more
Washington University School of Medicine430 enrolled3 locationsNCT07296887
Recruiting
Phase 4

Fluid Challenge and Plasma Volume, During Surgery

Colorectal, CancerGynecologic CancerUrologic Cancer+2 more
Joachim Zdolsek60 enrolled1 locationNCT05726136
Recruiting
Not Applicable

BOLSTER: Learning New Skills to Thrive

Advanced CancerGynecologic CancerGastrointestinal Cancer
Dana-Farber Cancer Institute600 enrolled2 locationsNCT06936878
Recruiting

Assessment of Sexual Well-being in Patients With Gynecologic Cancer and Their Partners: the ONCOSEX Study

Gynecologic CancersSexual Wellness
Casa di Cura Dott. Pederzoli200 enrolled6 locationsNCT07557342
Recruiting

Lung Ultrasound in Critically Ill Obstetrics and Gynecological Patients

Gynecologic CancerUltrasoundLung Diseases+1 more
Ain Shams University64 enrolled1 locationNCT06728709
Recruiting
Not Applicable

Effect of Skin Closure Techniques on Body Image in Women Undergoing Gynecologic Surgery

Gynecologic CancersBody ImageSurgical Wound Closure Techniques
Başakşehir Çam & Sakura City Hospital140 enrolled1 locationNCT07327125
Recruiting
Phase 1Phase 2

Cabozantinib and Dostarlimab in Recurrent Gynecologic Carcinosarcoma

Endometrial CancerCarcinomaGynecologic Cancer+1 more
University of Alabama at Birmingham37 enrolled1 locationNCT05559879
Recruiting
Not Applicable

Prospective Evaluation of Pencil Beam Scanning Proton Therapy for Previously Irradiated Tumors

Breast CancerProstate CancerHead and Neck Cancer+4 more
The New York Proton Center1,800 enrolled1 locationNCT05313191